Population Health for Health Professionals - PowerPoint PPT Presentation

1 / 69
About This Presentation
Title:

Population Health for Health Professionals

Description:

Population Health for Health Professionals EMERGING INFECTIOUS DISEASES PART 1 What Are Emerging Infectious Diseases? These are human illnesses caused by ... – PowerPoint PPT presentation

Number of Views:161
Avg rating:3.0/5.0
Slides: 70
Provided by: scahecNet
Category:

less

Transcript and Presenter's Notes

Title: Population Health for Health Professionals


1
Population HealthforHealth Professionals
2
EMERGING INFECTIOUS DISEASES
  • PART 1

3
Purpose
  • The purpose of this module is to provide an
    exposure to some of the emerging diseases that
    will affect the health of the public and to
    examine the challenges and opportunities they
    pose to the public health system

4
At the completion of this module you will be able
to
  • Describe the causes and contributing factors
    which lead to the emergence of infectious
    diseases.
  • Describe the latest emerging infections which
    have the potential to threaten people living in
    the United States.
  • Describe some of the measures that can be used to
    control and contain these diseases

5
What Are EmergingInfectious Diseases?
  • These are human illnesses caused by
    microorganisms or their poisonous byproducts and
    having the potential for occurring in epidemic
    numbers.

6
Why are we concerned about Emerging Infectious
Diseases?
  • These diseases
  • Pose a threat to all persons regardless of age,
    sex, lifestyle, ethnic background, or
    socioeconomic status
  • Cause suffering and death
  • Impose a financial burden on society

7
(No Transcript)
8
  • Over the past century, infectious diseases have
    decreased as a cause of death in this country
  • Improved sanitation, vaccination and antibiotics
    have played a large part in this decrease and are
    responsible to the increase in the lifespan of
    our residents
  • However, in the past twenty years the incidence
    of emerging infectious diseases has increased

9
FACTORS RELATED TO THE EMERGENCE OF INFECTIOUS
DISEASES
  • Factors studied Examples
  • 1. Biological----------Genes, microbes,
    medicines, vaccines, blood and organ transplants,
    rapid microbial adaptation and resistance to
    antibiotics
  • 2. Behavior----------Sports, nutrition,
    sexuality, tobacco, alcohol, international travel
  • 3. Environment physical--------Air, water,
    toxins, radiation, pollution, noise, agricultural
    development, climate change, technology
  • 4. Environment social ---------Housing,
    education, employment, and working conditions
  • 5. Environment human rights-------Discrimination
    , war, torture, physical and mental abuse, lack
    of access to health care, prevention and health
    education
  • 6. Breakdown of traditional basic public health
    infrastructure

10
  • An existing organism given the selective
    advantage by such things as a changing
    environmental condition and given the opportunity
    can infect a new host population
  • An organism can re-emerge in a drug resistant form

11
  • In the US, about 25 of physician visits are
    attributed to infectious diseases
  • In 1993, direct and indirect costs were estimated
    to be more than 120 billion. Today, these costs
    are substantially more

12
Economic and Social Impact of Some Infectious
Diseases
Economic and Societal Impact of Some Infectious
Diseases
13
How Are Infectious Diseases Acquired?
  • Inhalation
  • Ingestion
  • Food, water, soil
  • Percutaneous inoculation
  • Absorption from mucous membranes
  • Exposure to blood and body fluids

14
CDCs Target Areas
  • Antimicrobial resistance
  • Foodborne and waterborne diseases
  • Vectorborne and zoonotic diseases
  • Diseases transmitted through blood transfusions
    or blood products
  • Chronic diseases caused by infectious agents

15
CDCs Target Areas (cont.)
  • Vaccine development and use
  • Diseases of persons with impaired host defenses
  • Diseases of pregnant women and newborns
  • Diseases of travelers, immigrants, and refugees

16
CONTROL MEASURES
  • Water treatment
  • Vector control
  • Rodent reduction
  • Vaccination
  • Antibiotics

17
ROLE OF PUBLIC HEALTH
  • Surveillance and early response (detect,
    investigate, initiate action and monitor)
  • Assessment of health status, risks, and services
    available to a community
  • Development of health policy
  • Assurance of quality services (discourage
    inappropriate use of antibiotics)
  • Laboratory identification

18
ROLE OF PUBLIC HEALTH (CONT.)
  • Rapid communication with medical providers and
    hospitals
  • Communication with the media
  • Public and health care provider education (role
    in transmission, modification of lifestyle to
    avoid disease, etc.)
  • Environmental assessment and remediation, e.g.
    food inspection, water supply inspection, vector
    control)

19
EMERGING INFECTIOUS DISEASES
  • PART 2

20
New EmergingInfectious Diseases
  • The following diseases have recently emerged
    as public health concerns and will be discussed
    more fully in the slides that follow
  • Atypical Influenza
  • Severe Acute Respiratory Syndrome (SARS)
  • West Nile encephalitis (WNV)
  • Monkey Pox
  • Ebola
  • Hantavirus

21
INFLUENZA and ATYPICAL INFLUENZA
22
(No Transcript)
23
Influenza USA annual stats
  • 10-20 of population contract influenza annually
  • 36,000 die (excess mortality), more than 90 are
    65 and older
  • 226,000 hospitalizations (2004 data)
  • 38 million missed school days, 70 million missed
    work days
  • 1-3 Billion in direct costs

R. Ball, MD, MPH
24
Worldwide 3 to 5 million people are infected with
influenza each year with 250,000 to 500,000 deaths
25
Major Influenza Pandemics of the Twentieth Century
Excess US Mortality
Major Years
Subtype
17-18 H1N1 550,000 57-58 H2N2
70,000 68-69 H3N2 36,000 NEXT ? H5N1
(Avian) ?
26
Influenza Surface Proteins
Neuraminidase (N)
Hemagglutinin (H)
RNA (highly mutagenic)
M2 protein (only on type A)
27
The Usual Human Influenza A Strains within the
Last Century
Major influenza surface antigens Hemagglutinin
Neuraminidase
Asian Flu
Hong Kong Flu
1920
1957
1968
1977
2003
Thanks to Eric Brenner, MD for slide.
28
The Wider Family of Influenza Critters
15H x 9N? 135 potential HN combinations H5N1
already spreading in SE Asia (mortality 1 in 2)
inefficient person-person transmission USA is
developing a limited vaccination program vs. A/
H5N1 Avian Flu
H5N1

Slide by Eric Brenner, MD R. Ball, MD, MPH
29
Emergence of New Influenza A Virus Subtypes in
Humans
Thanks to JJ Gibson, MD for graph.
30
Is this virus actively reassorting its genes to
achieve a unique combination of virulence
and communicability?
Thanks to Eric Brenner, MD for slide.
31
  • Avian influenza A (H5N1) that infects poultry is
    a concern due to the potential for spread of an
    influenza A variant to humans, and the
    eventuality of human to human transmission, and a
    pandemic of atypical influenza.
  • Recent reports from several Asian countries that
    are experiencing Asian flu outbreaks in flocks
    of chickens indicate that humans have been
    infected who live or work in close proximity to
    those flocks of chickens

32
Avian Influenza may well be the pandemic in
waiting
33
  • Even if an epidemic is not deliberately caused by
    an altered strain of influenza virus, an epidemic
    or pandemic originating from natural origins will
    more than likely occur

34
If Pandemic Influenza Came Today...
  • Up to 200 million people infected
  • Up to 50 million people requiring care
  • Up to 2 million hospitalizations
  • Between 100,000 and 500,000 deaths
  • just in the USA

35
(No Transcript)
36
THE INFLUENZA CLOCK IS TICKING, WE JUST DONT
KNOW WHAT TIME IT IS
  • Ed Marcuse, MD and past chairman, The National
    Vaccine Advisory Committee

37
  • SARS (SEVERE ACUTE
  • RESPIRATORY SYNDROME)

38
A Novel Virus SARS
NEJM May 15, 2003
39
SARS-BASIC FACTS
  • SARS is an illness which can vary in severity and
    is caused by a Corona virus most likely of animal
    origin, e. g. civet
  • The disease is spread by large respiratory
    droplets from sneezing and coughing within a
    radius of 6 to 8 feet.
  • Incubation period-3 to 10 days
  • It can survive on surfaces up to 3 days but is
    easily killed by standard disinfectants

40
SARS Summary Points - 1
  • In retrospect epidemic started November 2002 in
    Southern China
  • WHO issues Global Alert March 2002
  • February 2003 very infectious patient infects
    many guests at Metropole Hotel in Hong Kong who
    in turn spread SARS to their own countries
  • World attention remained focused on SARS until
    global surveillance shows all chains of
    transmission interrupted July 2003

41
MMWR March 28, 2003 / Vol. 52 / No. 12
Hong Kong Metropole Hotel index case. Example of
a super-spreader.
42
Is there a small subset of SARS patients who
account for a disproportionate share of
transmission? MMWR May 9, 2003 / Vol. 52 / No. 18
- I
Patients No 1, 6, 35, 130127 seemed to be
hypertransmitters
43
SARS news www.cnn.com
ThursdayMay 15,2003
R. Ball, MD, MPH
44
WHO consensus document on the epidemiology of
SARS Selected conclusions
  • The report found no evidence that SARS is an
    airborne disease
  • Health Care Workers were at special risk,
    especially those involved with aerosol-generating
    procedures
  • The risk of transmission is greatest around day
    10 of the illness
  • Children were rarely affected by SARS
  • The implications of the events at the Metropole
    Hotel are not yet fully understood


45
The Return of SARS--2004
  • SARS reoccurred in China in 2004
  • There were nine cases
  • WHO issued a Global Health Advisory
  • The outbreak was contained 5/18/04, but WHO
    advised continued vigilance

46
The return of SARS - 2004 Summary Comments
  • SARS improved the ability of public health to
    conduct surveillance, investigate, and establish
    control measures for an infectious respiratory
    disease with (then) apparently pandemic potential
  • How extraordinary to have lived through the first
    global outbreak which was managed in real-time by
    means of public health measures, the Internet,
    and teleconferencing calls (e.g. between WHO,
    CDC, Hong-Kong, Singapore, Toronto, etc.)

47
The return of SARS - 2004 Summary Comments
  • How extraordinary to have lived through the first
    global outbreak which was managed in real-time by
    means of public health measures, the Internet,
    and teleconferencing calls (e.g. between WHO,
    CDC, Hong-Kong, Singapore, Toronto, etc.)

48
SARS over its peak ?
June 5 19,2003
R. Ball, MD, MPH
49
SARS were unprepared
www.gao.gov
http//www.gao.gov/new.items/d031058t.pdf
R. Ball, MD, MPH
50
(No Transcript)
51
WEST NILE VIRUS
52
FACTS ABOUT WNV
  • West Nile Fever is a flu-like illness of sudden
    onset, caused by a subgroup of viruses called
    Flavoviruses
  • Symptoms fever, sore throat, headache, malaise,
    arthralgia or myalgia. Rash is common.
  • Complications meningitis or encephalitis
    (inflammation of the brain tissue or the
    covering of the brain) can occur. The disease is
    then named West Nile neuroinvasive disease
  • Reservoir certain birds

53
FACTS ABOUT WNV
  • Incubation period usually 3 to 12 days
  • Communicability no direct person to person
    transmission Mode of transmission the bite of an
    infected mosquito
  • Prevention Mosquito eradication, mosquito
    repellents
  • Treatment none specific
  • Mortality rate 3 to 15

54
West Nile Virus a novelty becoming endemic
55
West Nile VirusUS 2003-CDC
56
MONKEY POX
  • Monkey pox, an Orthopox virus caused infection,
    closely resembles small pox clinically
  • Recently transmitted to humans by prairie dogs
    infected by a Gambian giant rat imported from
    Africa
  • Symptoms fever, rash, muscle aches, cough
  • Mortality 1 to 10 in Africa, none in the US

57
MONKEY POX
  • Transmission person to person has occurred
  • Treatment antibiotics, small pox vaccination if
    early in the course of the disease
  • Prevention small pox vaccination is partially
    successful, public education about the dangers of
    illegally imported pets

58
A New Infectious Disease Outbreak
NEJM 3504, 1-22-04
59
The next two diseases, Ebola and Hantaviral
pulmonary disease, are caused by a group of
similar viruses. They are generally classified
as Hantaviral diseases.
60
EBOLA
  • Mode of transmission handling infected wild
    animals
  • Incubation period 2 to 21 days
  • Transmission may be spread person to person by
    contact with body secretions
  • Treatment supportive
  • Prevention caution in contact with infected
    monkeys

61
SUDAN 2004 20 cases and 5 deaths Outbreak
coming under control now
62
HANTAVIRUS PULMONARY SYNDROME
  • Hantavirus pulmonary syndrome or hanta virus
    disease is caused by a Sin Nombre virus which has
    its reservoir in certain varieties of mice,
    principally the deer mouse.
  • Infected rodents shed virus in urine, droppings
    and saliva. Humans become ill when breathing in
    dried aerosolized mouse excreta.
  • Symptoms range from mild to severe. Fever,
    myalgias, gastrointestinal complaints, pneumonia
  • Complications blood dyscrasias, respiratory
    failure and shock

63
EBOLA
  • This is a severe viral illness caused by the
    Ebola virus (Filoviridae family) with its
    reservoir in chimpanzees and gorillas
  • Symptoms sudden onset of fever, myalgia,
    headache, followed by vomiting, diarrhea, and
    rash.
  • Mortality from 50 to 90 in Africa
  • Complications In severe forms, multiorgan
    failure occurs, primarily hemorrhagic and
    pulmonary complications

64
HANTAVIRUS PULMONARY SYNDROME (CONT.)
  • Mortality up to 50
  • Incubation period a few days to six weeks
  • Communicability no human to human transmission
  • Treatment supportive
  • Prevention rodent control, public education and
    caution

65
  • There are other infectious agents that will be
    the emerging infectious diseases of the future.
    We must be vigilante as a society and do our best
    to prevent their emergence by learning the
    lessons that the diseases we are dealing with
    today are teaching us.

66
YOUR ROLE IN DETECTION OF EMERGING INFECTIONS
  • Participate in surveillance activities in your
    clinical setting
  • Know your resources and who to call for
    consultation
  • Report to local health department

67
Note to the reader
  • Having just completed the module Emerging
    Infectious Diseases, you should proceed with
    either modules (5b) Environmental Impacts on
    Health or (5c) The Future of Health and Health
    Care
  • or
  • Proceed with the modules on Bioterrorism

68
At the completion of modules 5(b c) you will be
able to
  • Describe how various components of the
    environment affect the publics health
  • Identify the roles and responsibilities of the
    health care provider in confronting health care
    threats related to the environment
  • Discuss the health care needs of individuals and
    communities in the future
  • Identify roles and responsibilities of different
    components of the public health system in
    confronting health challenges

69
At the completion of modules titled Bioterrorism
- South Carolina at Risk and Bioterrorism -
South Carolina Responds, you should be able to
  • Understand the concept of terrorism
  • Understand how biological agents can be used as
    terrorist weapons
  • Describe the characteristics of those biologic
    agents thought to be the choice of terrorists
  • Understand the regional response to a
    bioterrorist act and the use of the unified
    incident/management command system
  • Describe the role and responsibility of each
    responding agency
  • Raise other issues that must be dealt with in
    planning a response to a bioterrorist act
Write a Comment
User Comments (0)
About PowerShow.com